- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 9.99M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $598K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $100.2M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $50.17M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.6B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.57B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.78B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.75B |
| Net Income | Q1 2025 · Dec 31, 2024 | $2.7M |
| Net Income | Q1 2025 · Sep 30, 2024 | $3.29M |
| Net Income | Q1 2025 · Jun 30, 2024 | $3.68M |
| Net Income | Q1 2025 · Mar 31, 2024 | $4.09M |
| Stockholders Equity | Q1 2025 · Sep 30, 2024 | $180.15M |
| Stockholders Equity | Q1 2025 · Jun 30, 2024 | $176.05M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $172.82M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $173.33M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 10.44M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $3.35M |
| Capex | Q1 2025 · Mar 31, 2024 | $214K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $9.15M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.39 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.39 |